eHealth-supported decentralized multi-disciplinary care for gout involving rheumatology, pharmacy, and dietetics: proof-of-concept study
To conduct quantitative and qualitative evaluation of an electronic health (eHealth)-supported decentralized multi-disciplinary care model for gout involving rheumatologists, pharmacist, and dietitian.
We conducted a 12-month proof-of-concept study. Gout patients with ≥ 1 flare in the past year and serum urate (SUA) ≥ 360 μmol/L within the previous 2 months were followed by participating community rheumatologists on an as-needed basis, received monthly telephone consults with a pharmacist, and one telephone consult with a dietitian. Healthcare professionals were not co-located but had shared access to the rheumatologists’ electronic medical records (EMR) for remote communication and collaboration. In quantitative evaluation, the primary outcome was the proportion of patients with SUA < 360 μmol/L at 12 months. In qualitative evaluation, we conducted semi-structured interviews with a subset of patients and applied constructivist grounded theory to gather patients’ perspectives.
Overall, 35 gout patients (86% males, mean age 60.9 ± 14.9 years) participated. At 12 months, 72% of patients achieved target SUA < 360 μmol/L. Qualitative analysis of interviews with a subset of 12 patients resulted in two themes: (1) experiences with receiving care, including categories of improved knowledge about gout, receiving personalized support, and knowing someone cares, and (2) practical considerations, including categories of optimizing timing of care and coordination and accessibility.
• We demonstrated the feasibility and impact of an eHealth-supported, decentralized collaborative care model for gout involving rheumatology, pharmacy, and dietetics
• Although prior multi-disciplinary models of care for gout have been reported, the novelty of our model is that healthcare providers are not co-located, lending to potential efficiencies and outreach to patients in rural areas
KeywordsDietetics Gout Models of care Pharmacy Rheumatology
The authors thank all participants in the study and our collaborators at Plexia Electronic Medical Systems for technical support provided for the study. The authors thank Drs. John Esdaile, Nicole Bauer, David Collins, and Shahin Jamal for their rheumatologic contributions to the study.
Dr. Mary De Vera is a recipient of a Scholar Award from the Michael Smith Foundation for Health Research and holds a Tier 2 Canada Research Chair.
Ms. Howren was supported by a Master’s Award from the Canadian Institutes of Health Research—Canada Graduate Scholarships—Master’s (CGS-M) Program for her work related to this study.
Dr. Avina-Zubieta is a recipient of Scholar Award from the Michael Smith Foundation for Health Research and is the BC Lupus Research Scholar.
This study was supported by an operating grant from the Canadian Initiative for Outcomes in Rheumatology Care and a team grant titled, ‘PRECISION: Preventing Complications from Inflammatory Skin, Joint and Bowel Conditions’ (FRN#THC-135235) from the Canadian Institutes of Health Research.
Compliance with ethical standards
Ethics approval and consent to participate
This study was reviewed and approved by the University of British Columbia Clinical Research Ethics Board (H14-01465) and Behavioural Research Ethics Board (H16-02061). Written consent was received from all study participants.
Consent for publication
HKC reports grants from AstraZeneca and consulting fees from Takeda, Selecta, and Horizon outside of the submitted work.
The other authors have disclosed no conflicts of interest.
- 3.Rai SK, Avina-Zubieta JA, McCormick N, De Vera MA, Shojania K, Sayre EC, Choi HK (2017) The rising prevalence and incidence of gout in British Columbia, Canada: population-based trends from 2000 to 2012. Semin Arthritis Rheum 46(4):451–456. https://doi.org/10.1016/j.semarthrit.2016.08.006 CrossRefPubMedGoogle Scholar
- 10.Doherty M, Jenkins W, Richardson H, Sarmanova A, Abhishek A, Ashton D, Barclay C, Doherty S, Duley L, Hatton R, Rees F, Stevenson M, Zhang W (2018) Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial. Lancet 392(10156):1403–1412CrossRefGoogle Scholar
- 11.Goldfien RD, Ng MS, Yip G, Hwe A, Jacobson A, Pressman A, Avins AL (2014) Effectiveness of a pharmacist-based gout care management programme in a large integrated health plan: results from a pilot study. BMJ Open 4(1):e003627. https://doi.org/10.1136/bmjopen-2013-003627 CrossRefPubMedPubMedCentralGoogle Scholar
- 13.Coburn BW, Cheetham TC, Rashid N, Chang JM, Levy GD, Kerimian A, Low KJ, Redden DT, Bridges SL Jr, Saag KG, Curtis JR, Mikuls TR (2016) Rationale and design of the randomized evaluation of an Ambulatory Care Pharmacist-Led Intervention to Optimize Urate Lowering Pathways (RAmP-UP) Study. Contemp Clin Trials 50:106–115CrossRefGoogle Scholar
- 14.Mikuls TR, Cheetham TC, Levy GD, Rashid N, Low KJ, Coburn BW, Saag KG, Chen L, Curtis JR (2017) Improving Gout Outcomes: The Randomized Evaluation of an Ambulatory Care Pharmacist-Led Intervention to Optimize Urate Lowering Pathways (RAmP-Up) Study. Paper presented at the American College of Rheumatology Conference, San Diego, CA, USAGoogle Scholar
- 15.Fields TR, Rifaat A, Yee AMF, Ashany D, Kim K, Tobin M, Oliva N, Fields K, Richey M, Kasturi S, Batterman A (2017) Pilot study of a multidisciplinary gout patient education and monitoring program. Semin Arthritis Rheum 46(5):601–608. https://doi.org/10.1016/j.semarthrit.2016.10.006 CrossRefPubMedGoogle Scholar
- 24.EuroQol--a new facility for the measurement of health-related quality of life (1990) Health Policy 16 (3):199-208Google Scholar
- 28.Charmaz K (2014) Constructing grounded theory, 2nd edn. SAGE Publications, LondonGoogle Scholar
- 30.Rai SK, Choi HK, Choi SHJ, Townsend AF, Shojania K, De Vera MA (2018) Key barriers to gout care: a systematic review and thematic synthesis of qualitative studies. Rheumatology 17:17Google Scholar
- 32.Burmester GR (2018) Response to: ‘digital health: a new dimension in rheumatology patient care’ by Kataria and Ravindran. Ann Rheum Dis 02:02Google Scholar
- 37.Gaffo AL, Schumacher HR, Saag KG, Taylor WJ, Dinnella J, Outman R, Chen L, Dalbeth N, Sivera F, Vazquez-Mellado J, Chou CT, Zeng X, Perez-Ruiz F, Kowalski SC, Goldenstein-Schainberg C, Chen L, Bardin T, Singh JA (2012) Developing a provisional definition of flare in patients with established gout. Arthritis Rheum 64(5):1508–1517CrossRefGoogle Scholar